120 related articles for article (PubMed ID: 12898039)
1. [Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy].
Paiss T; Bock B; Gschwend JE; Heinz H; Vogel W; Kron M; Hautmann RE; Herkommer K
Urologe A; 2003 Jul; 42(7):946-53. PubMed ID: 12898039
[TBL] [Abstract][Full Text] [Related]
2. Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy.
Paiss T; Herkommer K; Bock B; Heinz H; Vogel W; Kron M; Kuefer R; Hautmann RE; Gschwend JE
Eur Urol; 2003 Jun; 43(6):615-21. PubMed ID: 12767361
[TBL] [Abstract][Full Text] [Related]
3. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
[TBL] [Abstract][Full Text] [Related]
4. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
[TBL] [Abstract][Full Text] [Related]
5. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
6. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
[TBL] [Abstract][Full Text] [Related]
7. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with familial versus sporadic prostate cancer.
Roehl KA; Loeb S; Antenor JA; Corbin N; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 1):2438-42; discussion 2442. PubMed ID: 17085123
[TBL] [Abstract][Full Text] [Related]
9. Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.
Thalgott M; Kron M; Brath JM; Ankerst DP; Thompson IM; Gschwend JE; Herkommer K
World J Urol; 2018 Feb; 36(2):177-185. PubMed ID: 29164326
[TBL] [Abstract][Full Text] [Related]
10. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Cremers RG; Aben KK; van Oort IM; Sedelaar JP; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2016 Jul; 76(10):897-904. PubMed ID: 26989049
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological features of hereditary prostate cancer.
Keetch DW; Humphrey PA; Smith DS; Stahl D; Catalona WJ
J Urol; 1996 Jun; 155(6):1841-3. PubMed ID: 8618269
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute.
Guillonneau B; el-Fettouh H; Baumert H; Cathelineau X; Doublet JD; Fromont G; Vallancien G
J Urol; 2003 Apr; 169(4):1261-6. PubMed ID: 12629339
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.
Wiegel T; Bartkowiak D; Bottke D; Thamm R; Hinke A; Stöckle M; Rübe C; Semjonow A; Wirth M; Störkel S; Golz R; Engenhart-Cabillic R; Hofmann R; Feldmann HJ; Kälble T; Siegmann A; Hinkelbein W; Steiner U; Miller K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):288-94. PubMed ID: 25445556
[TBL] [Abstract][Full Text] [Related]
15. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
16. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
Huang SP; Huang CY; Wu WJ; Pu YS; Chen J; Chen YY; Yu CC; Wu TT; Wang JS; Lee YH; Huang JK; Huang CH; Wu MT
Int J Cancer; 2006 Oct; 119(8):1902-7. PubMed ID: 16708371
[TBL] [Abstract][Full Text] [Related]
17. Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer.
Reis ST; Viana NI; Leite KR; Diogenes E; Antunes AA; Iscaife A; Nesrallah AJ; Passerotti CC; Srougi V; Pontes-Junior J; Salles ME; Nahas WC; Srougi M
PLoS One; 2016; 11(12):e0166380. PubMed ID: 27906997
[TBL] [Abstract][Full Text] [Related]
18. [Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].
Herkommer K; Paiss T; Merz M; Gschwend JE; Kron M
Urologe A; 2006 Dec; 45(12):1532-9. PubMed ID: 17004091
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
20. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
Ward JF; Blute ML; Slezak J; Bergstralh EJ; Zincke H
J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
